Literature DB >> 23197686

Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.

Akira Mima1, Weier Qi, Junko Hiraoka-Yamomoto, Kyoungmin Park, Motonobu Matsumoto, Munehiro Kitada, Qian Li, Koji Mizutani, Edward Yu, Takeshi Shimada, Jongsoon Lee, Steven E Shoelson, Christian Jobin, Christian Rask-Madsen, George L King.   

Abstract

PURPOSE: To correlate changes between VEGF expression with systemic and retinal oxidative stress and inflammation in rodent models of obesity induced insulin resistance and diabetes.
METHODS: Retinal VEGF mRNA and protein levels were assessed by RT-PCR and VEGF ELISA, respectively. Urinary 8-hydroxydeoxyguanosine (8-OHdG), blood levels of C-reactive protein (CRP), malondialdehyde (MDA), and CD11b/c positive cell ratio were used as systemic inflammatory markers. Retinal expression of Nox2, Nox4, and p47phox mRNA levels were measured as oxidative stress markers. TNF-α, inter-cellular adhesion molecule-1 (ICAM-1), IL1β, and activation of nuclear factor κB (NF-κB) were used as retinal inflammatory markers.
RESULTS: Retinal VEGF mRNA and protein expression increased in Zucker diabetic fatty (ZDF(fa/fa)) rats and streptozotosin (STZ) induced diabetic Sprague-Dawley rats, after two months of disease, but not in Zucker fatty (ZF) rats. Systemic markers of oxidative stress and inflammation were elevated in insulin resistant and diabetic rats. Some oxidative stress and inflammatory markers (TNF-α, IL-6, ICAM-1, and IL1-β) were upregulated in the retina of ZDF(fa/fa) and STZ diabetic rats after 4 months of disease. In contrast, activation of NF-κB in the retina was observed in high fat fed nondiabetic and diabetic cis-NF-κB(EGFP) mice, ZF, ZDF(fa/fa), and STZ-induced diabetic rats.
CONCLUSIONS: Only persistent hyperglycemia and diabetes increased retinal VEGF expression. Some markers of inflammation and oxidative stress were elevated in the retina and systemic circulation of obese and insulin resistant rodents with and without diabetes. Induction of VEGF and its associated retinal pathologies by diabetes requires chronic hyperglycemia and factors in addition to inflammation and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197686      PMCID: PMC3753893          DOI: 10.1167/iovs.12-10207

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue.

Authors:  Eva Chou; Izumi Suzuma; Kerrie J Way; Darren Opland; Allen C Clermont; Keiko Naruse; Kiyoshi Suzuma; Nancy L Bowling; Chris J Vlahos; Lloyd Paul Aiello; George L King
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

2.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

3.  Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation.

Authors:  Toru Abiko; Atsuko Abiko; Allen C Clermont; Brett Shoelson; Naoichi Horio; Junichi Takahashi; Anthony P Adamis; George L King; Sven-Erik Bursell
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

4.  Vascular endothelial growth factor in diabetes induced early retinal abnormalities.

Authors:  Mark Cukiernik; Denise Hileeto; Terry Evans; Suranjana Mukherjee; Donal Downey; Subrata Chakrabarti
Journal:  Diabetes Res Clin Pract       Date:  2004-09       Impact factor: 5.602

5.  In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse.

Authors:  Scott T Magness; Humberto Jijon; Nancy Van Houten Fisher; Ned E Sharpless; David A Brenner; Christian Jobin
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 6.  Microvascular complications of impaired glucose tolerance.

Authors:  J Robinson Singleton; A Gordon Smith; James W Russell; Eva L Feldman
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

7.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

8.  Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.

Authors:  Giulio Romeo; Wei-Hua Liu; Veronica Asnaghi; Timothy S Kern; Mara Lorenzi
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.

Authors:  D C Darland; L J Massingham; S R Smith; E Piek; M Saint-Geniez; P A D'Amore
Journal:  Dev Biol       Date:  2003-12-01       Impact factor: 3.582

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  16 in total

Review 1.  Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.

Authors:  Akira Mima
Journal:  Adv Ther       Date:  2021-04-16       Impact factor: 3.845

2.  Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor.

Authors:  Chen-Yuan Gong; Bin Lu; Qian-Wen Hu; Li-Li Ji
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

3.  Obesity-associated Gingival Vascular Inflammation and Insulin Resistance.

Authors:  K Mizutani; K Park; A Mima; S Katagiri; G L King
Journal:  J Dent Res       Date:  2014-04-17       Impact factor: 6.116

4.  PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.

Authors:  Mogher Khamaisi; Sayaka Katagiri; Hillary Keenan; Kyoungmin Park; Yasutaka Maeda; Qian Li; Weier Qi; Thomas Thomou; Danielle Eschuk; Ana Tellechea; Aris Veves; Chenyu Huang; Dennis Paul Orgill; Amy Wagers; George L King
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

5.  Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats.

Authors:  Klaudia Szabó; Anna Énzsöly; Bulcsú Dékány; Arnold Szabó; Rozina I Hajdú; Tamás Radovits; Csaba Mátyás; Attila Oláh; Lenke K Laurik; Gábor M Somfai; Béla Merkely; Ágoston Szél; Ákos Lukáts
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  The role of insulin resistance in experimental diabetic retinopathy-Genetic and molecular aspects.

Authors:  Patrick Järgen; Axel Dietrich; Andreas W Herling; Hans-Peter Hammes; Paulus Wohlfart
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

7.  Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.

Authors:  Qiaoyun Gong; Fuqiang Li; Jia'nan Xie; Guanfang Su
Journal:  Endocrine       Date:  2019-04-12       Impact factor: 3.633

8.  Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats.

Authors:  Paulus Wohlfart; Jihong Lin; Nadine Dietrich; Aimo Kannt; Ralf Elvert; Andreas W Herling; Hans-Peter Hammes
Journal:  Acta Diabetol       Date:  2014-01-30       Impact factor: 4.280

Review 9.  Incretin-Based Therapy for Prevention of Diabetic Vascular Complications.

Authors:  Akira Mima
Journal:  J Diabetes Res       Date:  2015-12-31       Impact factor: 4.011

10.  Obesity-associated glomerular inflammation increases albuminuria without renal histological changes.

Authors:  Akira Mima; Toshinori Yasuzawa; George L King; Shigeru Ueshima
Journal:  FEBS Open Bio       Date:  2018-02-26       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.